The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 4306 -4312
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803462

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, S. J.
Right arrow Articles by Mehrad, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, S. J.
Right arrow Articles by Mehrad, B.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

Early NK Cell-Derived IFN-{gamma} Is Essential to Host Defense in Neutropenic Invasive Aspergillosis1

Stacy J. Park*, Molly A. Hughes{ddagger}, Marie Burdick{dagger}, Robert M. Strieter{dagger} and Borna Mehrad2,*,{dagger}

* Department of Microbiology, and Divisions of {dagger} Pulmonary and Critical Care Medicine and {ddagger} Infectious Diseases, Department of Medicine, University of Virginia, Charlottesville, VA 22908

Invasive aspergillosis is among the most common human fungal infections and occurs in patients with severe and complex defects in immune responses. NK cells have previously been found to be important in host defense against this infection, but the mechanism of this effect is not known. We hypothesized that NK cells mediate their protective effect in invasive aspergillosis by acting as the major source of IFN-{gamma} during early infection. We found that, in the lungs of neutropenic mice with invasive aspergillosis, NK cells were the major population of cells capable of generating IFN-{gamma} during early infection. Depletion of NK cells resulted in reduced lung IFN-{gamma} levels and increased lung fungal load that was independent of T and B cell subsets. Depletion of NK cells and absence of IFN-{gamma} resulted in a similar increase in susceptibility to the infection, but depletion of NK cells in IFN-{gamma}-deficient hosts did not result in further increase in severity of the infection. NK cell-derived IFN-{gamma} caused enhanced macrophage antimicrobial effects in vitro and also resulted in greater expression of IFN-inducible chemokines in the lungs. Finally, transfer of activated NK cells from wild-type, but not IFN-{gamma}-deficient hosts, resulted in greater pathogen clearance from the lungs of both IFN-{gamma}-deficient and wild-type recipients. Taken together, these data indicate that NK cells are the main source of early IFN-{gamma} in the lungs in neutropenic invasive aspergillosis, and this is an important mechanism in the defense against this infection.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grant HL73848 and an American Lung Association Career Investigator Award (to B.M.).

2 Address correspondence and reprint requests to Dr. Borna Mehrad, P.O. Box 800546, Charlottesville, VA 22908. E-mail address: Mehrad{at}Virginia.edu

3 Abbreviation used in this paper: WT, wild type.




This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
S. J. Park and B. Mehrad
Innate Immunity to Aspergillus Species
Clin. Microbiol. Rev., October 1, 2009; 22(4): 535 - 551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.